8-K
Current Report
BRAINSTORM CELL THERAPEUTICS INC. Filed Acc 0001104659-22-102386
Material agreement · Executive or director change
- Item 1.01 Entry into a material definitive agreement
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading tm2226431d1_8k.htm…